web based presentation
web based presentation with http://www.mdnewscast.net

web based presentation

Medical Newscast

News for 29-Feb-24

Source: MedicineNet High Blood Pressure General
Sharp Drop in Blood Pressure After Rx May Be Risky for Some Heart Patients

Source: MedicineNet High Blood Pressure General
Even Small Rise in Blood Pressure Can Harm Black Patients

Source: MedicineNet Diabetes General
Chemo More Damaging to Hearts of Diabetics: Study

Source: MedicineNet Diabetes General
Health Tip: Prepare for Travel With Diabetes

Source: MedicineNet High Blood Pressure General
Bonus From Your Blood Pressure Med: Fewer Fractures?

Source: MedicineNet Diabetes General
Can Protein, Probiotics Help With Blood Sugar Control?

Source: MedicineNet High Blood Pressure General
More Research Cites Salt's Potential Health Risks

Source: MedicineNet High Blood Pressure General
High Blood Pressure Might Affect Some Kids' Thinking Ability

Source: MedicineNet Diabetes General
Standing or 'Easy' Walks May Help Type 2 Diabetics Control Blood Sugar

Source: MedicineNet High Blood Pressure General
Omega-3s a Recipe for Healthy Blood Pressure in Young Adults

Search the Web

web based presentation
html slides
html presentations
slides html
web bulletin boards
interest group
web discussion boards
multimedia conference
discussion group

The Best web based presentation website

All the web based presentation information you need to know about is right here. Presented and researched by http://www.mdnewscast.net. We've searched the information super highway far and wide to provide you with the best web based presentation site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
web based presentation.

web based presentation

Medical Newscast
For information about Medical Newscasts look no further. We have links to great resources regarding all forms of medical internet broadcasting.
Medical Newscast

The Internet has been touted as a global forum covering thousands of topics including web based presentation. What it lacks in human contact it makes up for in pages.

The major search engines have indexed tens of thousands of web based presentation websites. All of these sites have people behind them but how can you determine whether one site is better than another. We believe we have found the very best web based presentation sites and the links appears here:

Abundant as it is in written materials the Net is also, fortunately, a place where you can chat online with other people interested in web based presentation. There are lots of web based presentation chat related sites on the Net.

People passionate about web based presentation can meet online and exchange information in real time with each other. If you have ever attended a web based presentation convention then you will know how valuable these live exchanges can be.

web based presentation
html slides
html presentations
slides html
web bulletin boards
interest group
web discussion boards
multimedia conference
discussion group
vedio conference
html seminar
seminar html
conference multimedia
dreamweaver seminar
multimedia conferences
vidio conference
composite conference
video seminars
dv conference
streaming conference
web discussions
vide conference
ecommerce seminar
frontpage seminar
webdesign seminar
dreamweaver seminars
newsgroup
vidéo conference
multimedia seminars
ecommerce seminars
seminar webdesign
discussion
bulletin board
forums
enabled
personal information manager
calendaring
webbase
scheduler
canadian premed
pim
forum
weborganizer
mesothelioma
prostate cancer
Asbestos
Sarcomatoid
Chemotherapy
Raltitrexed
Ranpirnase
cisplatin
pemetrexed
Anti?Metabolites
corticosteroid
Radiotherapy


















a Cold; Starve a Tumor

 by: ARA Content

(ARA) - One of the most exciting developments in modern medicine has been the discovery that cancerous tumors have the potential of being "starved" out of existence, or at least into dormancy. Scientists, doctors and, of course, patients, are all anticipating the prospect that cancer patients may take a drug that will stop a tumor in its track by cutting off the blood supply that nourishes it.

At the core of this medical breakthrough was the discovery that every tumor needs to "recruit" its own blood supply to flourish and grow. Scientists also found out that tumors actively "participated" in this process by secreting certain growth chemicals that would attract blood vessels to the tumor. Having identified this process, the next step was to determine if drugs could be created that could somehow arrest or reverse the progress of blood vessels amassing around a tumor.

The result has been a highly dynamic and exciting area of medicine called anti-angiogenesis (meaning "against the formation of new blood vessels") that focuses on inhibiting the growth of cancer by developing drugs that will prevent tumors from growing in size.

Currently, there are several drug companies that are on the cusp of introducing drugs that will work by the process of anti-angiogenesis. Generally speaking, the drugs seek to improve survival rates of cancer patients, as well as increase the length of time that patients survive. And unlike conventional cancer therapies that have punishing side effects, the new drugs seem to demonstrate few or no side effects for most people. Furthermore, some of the studies show that by utilizing both conventional treatments like radiation and/or chemotherapy in conjunction with anti-angiogenesis drugs, the cumulative effect is even more powerful.

One highly regarded company that is at the forefront of developing anti-angiogenesis drugs is Aeterna Laboratories, based in Quebec, Canada and traded on the Nasdaq market under the ticker symbol, AELA. The company's premier product, Neovastat, is currently being tested in clinical trials for a variety of cancers including lung, renal (kidney) and multiple myeloma (bone marrow). The results for the renal and multiple myeloma tests are scheduled to wrap up by the end of 2002 and, if conclusive, will be submitted to the Federal Drug Administration for review.

Out of all the drugs under development, Neovastat is unique because of its multi-functionality, which is its ability to shut down two pathways recognized as being responsible for promoting angiogenesis (in contrast to other drugs which just block one pathway). In clinical trials, Neovastat has been shown to have no side effects in most people. This is obviously a big advantage for people who know the agony of nausea, exhaustion and/or hair loss that can accompany chemotherapy drugs. In tests, Neovastat has been given to people in liquid oral form, generally the preferable form of drug delivery for patients.

If you are a cancer patient interested in clinical trial participation, you can get information about current trials by calling (888)-349-3232 If you are an oncologist, please contact Claude Hariton, Ph.D., vice president of Clinical and Regulatory Affairs at (418) 652-8525 ext. 306. To learn more about anti-angiogenesis drugs and Aeterna Laboratories, visit the Aeterna Web site at www.aeterna.com.

About The Author

Courtesy ARA Content, www.ARAcontent.com; e-mail: info@ARAcontent.com

Google

http://www.medmeet.com/
Xbox online games | Forum On The Net | Present On The Net | Medical Newscast | Take Medicine Correctly

Doctors On-the-Net   Medical Meetings On The Net   Drugestore On-the-Net